Acutus Medical, Inc.
AFIB
$0.0302
-$0.0106-25.98%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 35.40% | 27.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 35.40% | 27.60% | |||
| Cost of Revenue | 25.15% | 9.49% | |||
| Gross Profit | 170.16% | 208.45% | |||
| SG&A Expenses | 10.27% | 4.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.37% | 7.72% | |||
| Operating Income | 20.30% | 24.22% | |||
| Income Before Tax | -60.66% | -125.41% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -60.66% | -125.41% | |||
| Earnings from Discontinued Operations | 98.02% | -767.93% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 74.92% | -513.46% | |||
| EBIT | 20.30% | 24.22% | |||
| EBITDA | 20.50% | 24.84% | |||
| EPS Basic | 74.92% | -511.04% | |||
| Normalized Basic EPS | 20.53% | -0.44% | |||
| EPS Diluted | 74.92% | -511.04% | |||
| Normalized Diluted EPS | 20.53% | -0.44% | |||
| Average Basic Shares Outstanding | -0.10% | 0.26% | |||
| Average Diluted Shares Outstanding | -0.10% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||